Name: Tirzepatide Feature: Tirzepatide is a weekly double agonist of glucose-dependent insulin-promoting peptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor. GIP and GLP-1 are hormones secreted by the intestine and can promote insulin secretion. Tirzepatide integrates two insulin promoting effects into a single molecule, representing a new class of drugs for the treatment of type 2 diabetes.
Composition: Assay: 99% Appearance: White powder CAS No. 2023788-19-2 Packing: 25kg Shelf Life:2 years Storage: Store in cool and dry area Certification:ISO.
Complaint
